PharmTech Europe, Weekly Alert
Having trouble viewing this e-mail? CLICK HERE

PharmTech Europe
12 June 2018

PHARMTECH.COM

CURRENT ISSUE

SUBSCRIBE

FORWARD

twitter twitter
advertisement

Top Stories

EMA Recommends Four Biosimilars for Approval

The agency has recommended approval of three biosimilar adalimumab products from Novartis, referencing AbbVie's Humira, and a biosimilar trastuzumab from Pfizer, referencing Roche's Herceptin.
/ read more /


New Research Hub Tackles Access to Vaccines

The Future Vaccine Manufacturing Hub will work with CPI as well as other UK institutions to address challenges of vaccine production and distribution so that the spread of new diseases can be effectively tackled.
/ read more /

Subscribe

Subscribers can enjoy each full issue of Pharm Tech Europe in print, or via Pharm Tech Europe apps.

subscription offers
subscribe
advertisement

advertisement

Industry News

Hospira Recalls Naloxone Hydrochloride

The company is recalling two lots of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe system due to particulate matter on the syringe plunger.
/ read more /


AAPS Announces 2018 Slate of Candidates

The American Association of Pharmaceutical Scientists (AAPS) board of directors announced the candidates for the 2018 AAPS board.
/ read more /


More Industry News
advertisement

Regulatory News

EMA Recommends Approval of Migraine Biologic

EMA has recommended marketing authorization for Aimovig (erenumab), a new treatment for migraine.
/ read more /


FDA Approves First Biosimilar to Amgen's Neulasta

The agency has approved Mylan's Fulphila (pegfilgrastim-jmdb) as the first US-approved biosimilar to Amgen's Neulasta (pegfilgrastim) to reduce infection risk during cancer treatment.
/ read more /


More Regulatory News

Bio/Pharma News

Anti-methamphetamine Antibody Moves to Clinic

Catalent's GPEx technology was used to develop antibody for anti-methamphetamine clinical study.
/ read more /


GE and CCRM Partner with DiscGenics on New Cell Therapy

GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) will support scale-up efforts by DiscGenics for a new cell therapy intended to treat back pain.
/ read more /


More Bio/Pharma News

Supplier News

MilliporeSigma and Solvias Partner on New Pyrogen Detection Kit

The new kit is expected to detect a broad spectrum of pyrogens while offering high reproducibility and sensitivity as well as eliminating the need for live animal testing.
/ read more /

 

Cambrex Adds Process Development Capabilities

Cambrex invests $5 million in new laboratory expansion at its Karlskoga, Sweden facility.
/ read more /


More Supplier News

FEATURED TOPICS

ANALYTICS

The Statistical Evaluation of Cleaning Processes Using Process Capability and its Application to New Product Introduction

The approach presented in this study uses process capability index results to establish sampling strategies for use with new product cleaning and to efficiently reduce the risk of insufficient cleaning.
/ read more /

 

PROCESS VALIDATION

Understanding Validation and Technical Transfer

Validation ensures safe and effective biologic products that benefit the patients whose health and wellbeing depend on the therapies.
/ read more /

DRUG DEVELOPMENT

Albumin Attachment Can Make Better Biobetters

Naturally occurring and engineered albumins are being explored as a tool to enhance the stability of drugs, including biologics, and extend shelf-life.
/ read more /

ASEPTIC/STERILE

Lies That Environmental Monitoring Systems Tell

Environmental monitoring, which operates below the limit of detection, is little more than a rote exercise that provides limited real value. So why does it figure so prominently in current regulatory requirements for aseptic manufacturing?
/ read more /


Product Profile

Significantly improved analytical productivity with automated pretreatment operations

Shimadzu's i-Series Plus expands the product line and improves performance and user-friendliness. With i-Series Plus, pretreatment operations have been automated, such as the processes to dilute samples and add reagents.
/ Read more/


LIVE WEBCAST

Continuous Processing in Biomanufacturing
Considerations for Adoption and Case Studies in Biologic Development and Manufacturing
Thursday, June 14, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now


ON DEMAND WEBCASTS

The Pharma Supply Chain Revolution
On Demand
Learn more


How to Package Highly Complex Biologics
On Demand
Learn more


Events

ACHEMA 2018

Frankfurt am Main, Germany

11–15 June 2018

Chemspec Europe 2018

Koelnmesse, Cologne

20–21 June 2018

3rd PDA Europe Annual Meeting

Berlin, Germany

26–27 June 2018

SMi's 13th Annual ADMET Conference

London, United Kingdom

9–10 July 2018

16th International Conference and Exhibition on Pharmaceutical Formulations

Rome, Italy

26–27 July 2018


more events

eBOOKS

Biologics and Sterile Drug Manufacturing 2018

This ebook covers novel technologies for the formulation, manufacture, purification, and delivery of sterile small- and large-molecule drugs, including single-use systems, facilities and equipment, contamination issues, and process analytics.

contribute | CONTACT EDITORS | CONTACT SALES | subscribe | advertise